Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: sulfa (sulfonamide antibiotics) / adhesive bandage attending: chief complaint: chief complaint: presyncope, palpitations reason for micu transfer: saddle pe major surgical or invasive procedure: none history of present illness: ms. is a 48f with h/o stage 4 jejunal adenocarcinoma with peritoneal mets, htn, dm2, hld, followed by dr , yergulun, on palliative chemotherapy with folfiri/bevacizumab. she was seen in clinic monday and was found to have superficial phlebitis of the left lower leg, which responded to heating pads. she now has worsening lower extremity pain now in the medial thigh, which was so severe that she felt like she was going to pass out. she endorsed palpitations. she presented to hospital, where an ultrasound showed new dvt, and she was started on heparin 1400/hr. no ct chest was performed; head ct was negative, no rectal recorded. osh labs: trop 0.47 ekg: nsttt. vitals at osh: 97.4 bp: 124/95 hr:104-124 97% 2l in the ed, initial vs were: temp: 98.8 ??????f (37.1 ??????c), pulse: 107, rr: 18, bp: 138/99, o2sat: 96%, o2flow: ra. cta showed large bilateral pe, saddle embolus at pulmonary artery; may also be clot extending into right ventricle, right atrium but difficult to tell due to motion. right heart . rec'd 500cc of ivf in ed. per cardiac surgery (dr cardiac attending on call), thrombolysis was preferred to thrombectomy. called cards (fellow, who discussed with dr , recommended admission to micu for tpa by intensivist. given recent dx of llq dz, decision made not to proceed with tpa given risks of gib. on arrival to the micu, patient is comfortable and not c/o any pain. denies cp, sob, pleuritic cp, abdom pain, ha, leg pain. ros: negative for blurry vision, headache, sob, cough, rash stable nausea, vomiting, diarrhea from chemotherapy. past medical history: past medical history: metastatic jejunal adenoca htn dm2 hld oncologic history: - early : began experiencing vague abdominal discomfort, bloating, intermittent nausea/vomiting, and weight loss from poor po intake. - : admitted to for sbo after mr enterography revealed dilatation of the proximal small bowel with a transition point in the mid-jejunum. just distal to the transition point, there was evidence of intussusception with a 2 cm stretch of circumferential bowel wall thickening concerning for a mass lesion. - : underwent exploratory laparotomy with dr. . intraoperatively, dr. described a " feet ... obscured jejunal strictured mass." he thus performed a resection of that segment of small bowel measuring 8.1 cm in length. pathology revealed a 2.7 cm x 2.1 cm x 1.1 cm poorly-differentiated invasive adenocarcinoma invading through the muscularis propria into the subserosa (pt3). there were six lymph nodes available for examination, four of which demonstrated metastatic adenocarcinoma (pn2). one of the lymph nodes demonstrated focal extracapsular extension of the tumor. of note, there was also adenoma with high-grade glandular dysplasia adjacent to an overlying epicenter of the invasive mass. surgical margins were negative with the closest margin being 3.5 cm at the proximal margin. there was evidence of lymphovascular invasion. there was no perineural invasion. kras g12v mutation confirmed; ihc for mlh1, pms2, msh2, and msh6 were intact; microsatellite stable (mss). - : began cycle 1 of modified folfox6, however cea noted to be quickly rising so no further treatment was given at the time. pet ct showed questionable increased uptake in portal lymph node. - : underwent repeat laparotomy to evaluate rising cea for possible wide excision of small bowel mesentery. intra-operatively, was found to have multiple small deposits along the small bowel mesentery, pathology of which confirmed metastatic adenocarcinoma. - : resumed mfolfox6 for palliation. chose to take a treatment break after her 12th (c7d1) dose on . social history: no tobacco, no etoh family history: no h/o cancer; father died of mi at 47; mother had clots and cad physical exam: admission physical exam: vitals: t 98.2 hr 100 bp 114/77 o2: 97% ra general: alert, oriented, no acute distress heent: sclera anicteric, mmm, oropharynx clear, eomi, perrl neck: supple, jvp not elevated, no lad cv: regular rate and rhythm, normal s1 + s2 with possible s4 at rus border, no murmurs, rubs, gallops lungs: clear to auscultation bilaterally, no wheezes, rales, ronchi abdomen: obese, some induration in lateral aspects, bowel sounds present, no organomegaly, no tenderness to palpation, no rebound or guarding gu: foley ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema; varicose veins throughout b/l le's discharge exam vitals - t:99.5 bp: 134-144/70-86 hr: 66-72 rr: 18-20 02 sat: 94% ra 560/150 general: nad obese skin: warm and well perfused, no excoriations or lesions, no rashes heent: at/nc, eomi, perrla, anicteric sclera, pink conjunctiva, patent nares, mmm, good dentition, nontender supple neck, no lad, no jvd cardiac: rrr, s1/s2, no mrg lung: minor bibasilar crackles, air movement throughout bilaterally. no wheezes. abdomen: obes abdomen, +bs, nontender in all quadrants, no rebound/guarding, no hepatosplenomegaly m/s: moving all extremities well, no cyanosis, clubbing or edema, no obvious deformities. prominent varicose vasculature in le. pulses: 2+ dp pulses bilaterally neuro: cn ii-xii intact, strength 5/5 bilaterally, finger to nose intact, sensation to light touch intact. pertinent results: admission labs: 06:45pm wbc-6.6 rbc-3.96* hgb-11.8* hct-36.8 mcv-93 mch-29.9 mchc-32.2 rdw-14.2 plt ct-178 06:45pm neuts-71.4* lymphs-25.7 monos-1.3* eos-1.3 baso-0.4 06:45pm pt-14.2* ptt-131.4* inr(pt)-1.3* 06:45pm glucose-161* urean-7 creat-0.5 na-141 k-4.1 cl-110* hco3-23 angap-12 04:08am calcium-8.2* phos-2.9 mg-2.2 07:00pm urine -neg nitrite-neg protein-neg glucose-neg ketone-neg bilirub-neg urobiln-neg ph-5.0 leuks-neg 05:57am pt-12.9* ptt-34.6 inr(pt)-1.2* 04:08am ck(cpk)-94 01:45pm ctropnt-0.09* 04:08am ck-mb-4 ctropnt-0.13* 06:45pm ctropnt-0.27* 06:45pm ck-mb-5 probnp-665* . imaging: . ct head (): no acute intracranial hemorrhage or edema. evaluation for metastasis is limited and would be better performed with a contrast mr . . ct chest (): impression: extensive pulmonary emboli involving all lobes with a saddle embolus across the main pa with signs of right heart . echo : the left atrium is elongated. no atrial septal defect is seen by 2d or color doppler. left ventricular wall thicknesses are normal. the left ventricular cavity is unusually small. regional left ventricular wall motion is normal. overall left ventricular systolic function is normal (lvef>55%). no masses or thrombi are seen in the left ventricle. there is no ventricular septal defect. the right ventricular cavity is dilated with moderate global free wall hypokinesis with apical sparing (positive sign for acute rv /pulmonary embolism). there is abnormal systolic septal motion/position consistent with right ventricular pressure overload. there is no mass/thrombus in the right ventricle. the diameters of aorta at the sinus, ascending and arch levels are normal. the aortic valve leaflets (3) appear structurally normal with good leaflet excursion and no aortic stenosis or aortic regurgitation. the mitral valve appears structurally normal with trivial mitral regurgitation. there is no mitral valve prolapse. the tricuspid valve leaflets are mildly thickened. there is mild pulmonary artery systolic hypertension. there is a trivial/physiologic pericardial effusion. there are no echocardiographic signs of tamponade. impression: acute rv with underfilled lv. echo : the left ventricular cavity size is normal. overall left ventricular systolic function is normal. the right ventricular cavity is dilated with severe global free wall hypokinesis. there is abnormal septal motion/position. the aortic valve leaflets (3) appear structurally normal with good leaflet excursion and no aortic stenosis or aortic regurgitation. the mitral valve appears structurally normal with trivial mitral regurgitation. tricuspid regurgitation is present but cannot be quantified. the pulmonary artery systolic pressure could not be determined. there is a trivial/physiologic pericardial effusion. compared with the prior study (images reviewed) of , the right ventricular overload is now improved although the right ventricle is still hypokinetic. discharge labs 05:57am wbc-3.4* rbc-3.35* hgb-10.4* hct-30.9* mcv-92 mch-31.0 mchc-33.5 rdw-15.1 plt ct-159 05:57am neuts-58.6 lymphs-32.8 monos-5.2 eos-2.9 baso-0.4 05:57am glucose-114* urean-8 creat-0.8 na-141 k-3.6 cl-105 hco3-28 angap-12 04:06am alt-7 ast-15 ld(ldh)-301* alkphos-69 totbili-0.2 05:57am calcium-8.0* phos-3.6 mg-2.1 brief hospital course: ms. is a 48f with h/o stage 4 jejunal adenocarcinoma with peritoneal mets on palliative chemotherapy with folfiri/bevacizumab, htn, dm2, hld, who p/w le pain and palpitations, found to have extensive pe's involving all lobes and a saddle embolus. active issues: # saddle pe and pe's: her main risk factor for pe is her malignancy. she was commenced on a heparin gtt at hospital after presenting there with le pain and a brief episode of lightheadedness. at the ed, cards, cardiac surgery, and cardiothoracic surgery were all consulted after the pe's were found on cta, and thrombolysis and thrombectomy were both considered but not undertaken. given her recent dx of new llq dz, the initial decision was made not to proceed with tpa given risks of gib. in the , she was maintained on a heparin gtt with goal ptt 80-100. on 5/14am, she became hypotensive and presyncopal, requiring a dopamine gtt and arterial line placement; cardiology was reconsulted and systemic tpa was given, with a plan to pursue catheter based thrombolysis only if systemic thrombolysis failed. she then remained hemodynamically stable. tachycardia improved and pressure remained stable. serial hcts were monitored after patient received tpa and patient's hct remained stable. repeat echo showed less rv , patient did not need embolectomy. there was discussion of whether the patient would benefit from ivc filter, in the event that she becomes thrombocytopenic with chemo and is unable to continue treatment. although this is a possibility, the decision was made to not pursue this intervention at this time. she was discharged on lovenox 100mg . chronic issues: # jejeunal adenocarcinoma with peritoneal mets: she is on palliative chemotherapy with folfiri/bevacizumab. # htn: held home lisinopril while admitted # dm2: iss while admitted # hld: held home tricor while admitted transitions of care: code status: full code contact: husband pending studies:none issues to address at follow up: anticoagulation with lovenox treamtent of cancer. medications on admission: home medications: (reviewed with pt ) tricor lisinopril 20mg daily metformin 500mg asa 81mg daily loratadine 10mg daily discharge medications: 1. enoxaparin 100 mg/ml syringe sig: one (1) subcutaneous q12h (every 12 hours). disp:*60 syringes* refills:*0* 2. tricor 145 mg tablet sig: one (1) tablet po once a day. 3. fluticasone 50 mcg/actuation spray, suspension sig: one (1) nasal once a day as needed for allergy symptoms. 4. lisinopril 20 mg tablet sig: one (1) tablet po once a day. 5. metformin 500 mg tablet sig: one (1) tablet po twice a day. 6. aspirin 81 mg tablet, chewable sig: one (1) tablet, chewable po once a day. 7. loratadine 10 mg tablet sig: one (1) tablet po once a day as needed for allergy symptoms. discharge disposition: home discharge diagnosis: primary diagnosis: jujeunal adenocarcinoma discharge condition: mental status: clear and coherent. level of consciousness: alert and interactive. activity status: ambulatory - independent. discharge instructions: dear mrs. , you were admitted for a large clot in your lungs. you received clot-busting medication and you did not experience bleeding complications. please note the following changes to your medications: - start lovenox followup instructions: department: hematology/oncology when: monday at 11:00 am with: , md building: sc clinical ctr campus: east best parking: garage department: hematology/oncology when: monday at 11:00 am with: , md building: sc clinical ctr campus: east best parking: garage department: hematology/oncology when: monday at 12:00 pm with: , rn building: campus: east best parking: garage procedure: injection or infusion of thrombolytic agent diagnoses: congestive heart failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypotension, unspecified long-term (current) use of other medications antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use acute systolic heart failure personal history of malignant neoplasm of other gastrointestinal tract secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes secondary malignant neoplasm of retroperitoneum and peritoneum acute venous embolism and thrombosis of deep vessels of distal lower extremity acquired absence of intestine (large) (small) other secondary thrombocytopenia saddle embolus of pulmonary artery 

Answer: The patient is high likely exposed to